Search by Drug Name or NDC
NDC 00338-1307-05 MESNEX 100 mg/mL Details
MESNEX 100 mg/mL
MESNEX is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Baxter Healthcare Corporation. The primary component is MESNA.
MedlinePlus Drug Summary
Mesna is used to reduce the risk of hemorrhagic cystitis (a condition that causes inflammation of the bladder and can result in serious bleeding) in people who receive ifosfamide (a medication used for the treatment of cancer). Mesna is in a class of medications called cytoprotectants. It works by protecting against some of the harmful effects of certain chemotherapy medications.
Related Packages: 00338-1307-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mesna Injection
Product Information
| NDC | 00338-1307 |
|---|---|
| Product ID | 0338-1307_c7badc4e-476a-4745-a4ba-73c794a6ca19 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | MESNEX |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | MESNA |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/mL |
| Substance Name | MESNA |
| Labeler Name | Baxter Healthcare Corporation |
| Pharmaceutical Class | Cytoprotective Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | NDA |
| Application Number | NDA019884 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00338-1307-05 (00338130705)
| NDC Package Code | 0338-1307-05 |
|---|---|
| Billing NDC | 00338130705 |
| Package | 1 VIAL in 1 BOX (0338-1307-05) / 10 mL in 1 VIAL (0338-1307-10) |
| Marketing Start Date | 2018-07-18 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |